Carnegie Investment Bank
Edit

Carnegie Investment Bank

http://www.carnegie.se/
Last activity: 02.09.2026
Active
Categories: BrokerCorporateFinTechManagementMarketMedTechProductResearchServiceSocial
Carnegie is a Nordic Investment Bank and market leader in the areas of Corporate Finance, Securities, and Private Banking. Carnegie brings investors, entrepreneurs, companies, institutions and private individuals
together to create innovative products, new jobs, private wealth and social progress. Carnegie operates in seven countries and has approximately 600 employees.
Website visits
42.2K /mo.
Mentions
797
Location: United States, New York
Employees: 501-1000
Founded date: 1803

Investors 1

DateNameWebsite
-Altor Equi...altor.com

Mentions in press and media 797

DateTitleDescription
02.09.2026Terranor AB awarded a framework agreement for Alingsås Energi with an expected annual volume between SEK 50–75 millionTerranor AB awarded a framework agreement for Alingsås Energi with an expected annual volume between SEK 50–75 million Wed, Sep 02, 2026 18:00 CET Report this content Terranor AB, a subsidiary of Terranor Group, has been awarded a framework...
01.09.2026Elicera Therapeutics receives its first notice of patent allowance for ELC-201 – a Japanese patent protecting the oncolytic virus candidate against solid tumorsElicera Therapeutics receives its first notice of patent allowance for ELC-201 – a Japanese patent protecting the oncolytic virus candidate against solid tumors Tue, Sep 01, 2026 14:06 CET Report this content Uppsala, September 1, 2026 – El...
31.08.2026Acquisitions of own shares in Paradox Interactive AB (publ) 24 – 28 August 2026Acquisitions of own shares in Paradox Interactive AB (publ) 24 – 28 August 2026 Mon, Aug 31, 2026 08:15 CET Report this content Paradox Interactive AB (publ) (“Paradox”) has, during the period 24 August – 28 August, acquired a total of 190,...
31.08.2026Repurchase of shares in Synsam during August 24, 2026 – August 28, 2026 (week 35)Repurchase of shares in Synsam during August 24, 2026 – August 28, 2026 (week 35) Mon, Aug 31, 2026 18:10 CET Report this content Synsam AB (publ) (LEI code: 5493000TMEGW9DHNOQ70) ("Synsam" or the "Company") has during A...
31.08.2026Harmoney BidCo AB (publ) publishes interim report for the second quarter of 2026Harmoney BidCo AB (publ) publishes interim report for the second quarter of 2026 Mon, Aug 31, 2026 09:00 CET Report this content Harmoney BidCo AB (publ) (the "Company"), issuer of EUR 130,000,000 Senior Secured Callable Floating ...
31.08.2026The Board of Directors of Paradox Interactive AB (publ) has resolved that the SEK 200 million share buyback program will be executed in accordance with the Safe Habour RegulationThe Board of Directors of Paradox Interactive AB (publ) has resolved that the SEK 200 million share buyback program will be executed in accordance with the Safe Habour Regulation Mon, Aug 31, 2026 20:45 CET Report this content On 5 August 2...
31.08.2026Buyback of shares in Besqab during August 24 - 28, 2026Buyback of shares in Besqab during August 24 - 28, 2026 Mon, Aug 31, 2026 08:00 CET Report this content Besqab AB (publ) (LEI code: 549300XFVKDYCN5GR726) ("Besqab" or the "Company") has during July 27, 2026 to July 31, 2...
31.08.202630th FH Ranking – Sweden’s Leading Financial Analysts and Financial Journalists by Sector 2026, Stockholm – 31 August 2026, 08:0030th FH Ranking – Sweden’s Leading Financial Analysts and Financial Journalists by Sector 2026, Stockholm – 31 August 2026, 08:00 Mon, Aug 31, 2026 08:33 CET Report this content PRESSRELEASE FH Ranking presents the sector results of the 30t...
31.08.2026Acquisitions of own ordinary shares of series A in Karnov GroupAcquisitions of own ordinary shares of series A in Karnov Group Mon, Aug 31, 2026 07:45 CET Report this content Karnov Group AB (publ) (“Karnov”) has, during the period 24 August – 28 August 2026, acquired a total of 5,000 own ordinary shar...
28.08.2026Elicera Therapeutics receives Notice of Allowance for U.S. patent application protecting the ELC-401 CAR T-cell candidateElicera Therapeutics receives Notice of Allowance for U.S. patent application protecting the ELC-401 CAR T-cell candidate Fri, Aug 28, 2026 10:08 CET Report this content Gothenburg, August 28, 2026 – Elicera Therapeutics AB (publ) (“Elicera...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In